Korea Looks To Close Gap In AI Drug Development Capabilities

Syntekabio Offering Multiple Platforms

 
• By Jung Won Shin
  
HeaKyoung Cho, CSO of Syntekabio
Syntekabio CSO HeaKyoung Cho • Source: Syntekabio

More from South Korea

More from Focus On Asia